Katedra i Klinika Okulistyki Uniwersytetu Medycznego w Lublinie

WYBRANE PUBLIKACJE

Żarnowski T., Tulidowicz-Bielak., Topical bevacizumab is efficacious in the early bleb failure after trabeculectomy. Acta Ophthalmologica, 2010, in press

Petzold A, Junemann A, Rejdak K, Zarnowski T, Thaler S, Grieb P, Kruse FE, Zrenner E, Rejdak R. A novel biomarker for retinal degeneration: vitreous body neurofilament proteins. J Neural Transm. 2009 Sep 22.

Piecyk-Sidor M., Polz-Dacewicz M., Zagorski Z., Żarnowski T., Occurrence of human papillomavirus in pterygia. Acta Ophthalmologica, 2009, 87, 890-895.

Thaler S, Fiedorowicz M, Rejdak R, Choragiewicz TJ, Sulejczak D, Stopa P, Zarnowski T, Zrenner E, Grieb P, Schuettauf F. Neuroprotective effects of tempol on retinal ganglion cells in a partial optic nerve crush rat model with and without iron load. Exp Eye Res. 2010 Nov 4.

Nowomiejska K, Rejdak R, Zagorski Z, Zarnowski T.: Comparison of static automated perimetry and semi-automated kinetic perimetry in patients with bilateral visible optic nerve head drusen. Acta Ophthalmol. 2008 Aug 20.

Thaler S, Haritoglou C, Choragiewicz TJ, Messias A, Baryluk A, May CA, Rejdak R, Fiedorowicz M, Zrenner E, Schuettauf F.: In vivo toxicity study of rhodamine 6G in the rat retina. Invest Ophthalmol Vis Sci. 2008 May;49(5):2120-6.

Mackiewicz J, Mühling B, Hiebl W, Meinert H, Kociok N, Joussen AM.:  Pneumatic retinopexy by evaporation of fluorocarbon liquids: in vitro and in vivo results. Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):69-79.

Rejdak R, Rummelt C, Zrenner E, Grieb P, Zarnowski T, Okuno E, Schlötzer-Schrehardt U, Naumann GO, Kruse F, Jünemann AG.: Immunohistochemical identification of kynurenine aminotransferases in corpora amylacea in the human retina and optic nerve. Folia Neuropathol. 2007;45(2):66-71.

Schuettauf F, Thaler S, Bolz S, Fries J, Kalbacher H, Mankowska A, Zurakowski D, Zrenner E, Rejdak R.: Alterations of amino acids and glutamate transport in the DBA/2J mouse retina; possible clues to degeneration. Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1157-68.

Zarnowski T, Rejdak R, Zielinska-Rzecka E, Zrenner E, Grieb P, Zagórski Z, Junemann A, Turski WA.:  Elevated concentrations of kynurenic acid, a tryptophan derivative, in dense nuclear cataracts. Curr Eye Res. 2007 Jan;32(1):27-32.

Schuettauf F, Rejdak R, Thaler S, Bolz S, Lehaci C, Mankowska A, Zarnowski T, Junemann A, Zagorski Z, Zrenner E, Grieb P.: Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat. Exp Eye Res. 2006 Nov;83(5):1128-34. Epub 2006 Jul 28.

Zarnowski T, Bialek M, Rejdak R, Zrenner E, Junemann A, Zagorski Z, Kocki T, Turski WA.: Kynurenic acid synthesis in bovine retinal slices--effect of glutamate agonists. J Neural Transm. 2006 Oct;113(10):1367-72.

Schuettauf F, Haritoglou C, May CA, Rejdak R, Mankowska A, Freyer W, Eibl K, Zrenner E, Kampik A, Thaler S.: Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study. Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3573-8.

Thaler S, Rejdak R, Dietrich K, Ladewig T, Okuno E, Kocki T, Turski WA, Junemann A, Zrenner E, Schuettauf F.: A selective method for transfection of retinal ganglion cells by retrograde transfer of antisense oligonucleotides against kynurenine aminotransferase II. Mol Vis. 2006 Feb 22;12:100-7.

Zarnowski T, Rejdak R, Zagorski Z, Juenemann AG, Zrenner E, Kocki T, Urbanska EM, Turski WA.: Content of kynurenic acid and activity of kynurenine aminotransferases in mammalian eyes. Ophthalmic Res. 2004 Mar-Apr;36(2):124-8.

Rejdak R, Zielinska E, Shenk Y, Turski WA, Okuno E, Zarnowski T, Zagorski Z, Zrenner E, Kohler K.: Ontogenic changes of kynurenine aminotransferase I activity and its expression in the chicken retina. Vision Res. 2003 Jun;43(14):1513-7.

Rejdak R, Zarnowski T, Turski WA, Kocki T, Zagorski Z, Zrenner E, Schuettauf F.: Alterations of kynurenic acid content in the retina in response to retinal ganglion cell damage. Vision Res. 2003 Mar;43(5):497-503.

W 2000 roku na Kongresie Jaskry w Londynie dr Żarnowski i dr Rejdak otrzymali pierwszą nagrodę za pracę na temat syntezy kwasu kynureninowego (substancji neuroprotekcyjnej) w gałce ocznej. Pracownicy Kliniki wielokrotnie otrzymali zespołową Nagrodę Ministra Zdrowia: w 2003 r. za cykl prac na temat syntezy kwasu kynureninowego w gałce ocznej, a 2004 r. za cykl prac na temat molekularnych mechanizmów jaskry, w 2005 r. nt chorób zwyrodnieniowych siatkówki, a w 2007 r. za cykl prac pt. „Nowe aspekty neurodegeneracji i terapii w retinologii”

Powrót